Report overview
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
This report contains market size and forecasts of Nanotechnology for Healthcare in Global, including the following market information:
Global Nanotechnology for Healthcare Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nanotechnology for Healthcare market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nanomedicine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nanotechnology for Healthcare include Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co and Biogen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nanotechnology for Healthcare companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nanotechnology for Healthcare Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nanotechnology for Healthcare Market Segment Percentages, by Type, 2021 (%)
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Global Nanotechnology for Healthcare Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nanotechnology for Healthcare Market Segment Percentages, by Application, 2021 (%)
Anticancer
CNS Product
Anti-infective
Other
Global Nanotechnology for Healthcare Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nanotechnology for Healthcare Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nanotechnology for Healthcare revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Nanotechnology for Healthcare revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
